Author

M. Mirandola

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

C. Salata· 2 shared A. Mirazimi· 1 shared C. Salaris· 1 shared G. Mastrangelo· 1 shared H. H. Wandall· 1 shared I. Bagdonaite· 1 shared L. Cegolon· 1 shared M. Frank· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. Salata

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Isoform-specific O-glycosylation dictates Ebola virus infectivity

I. Bagdonaite, S. Abdurahman, M. Mirandola, M. Frank, Y. Narimatsu, S. Y. Vakhrushev, C. Salata, A. Mirazimi, H. H. Wandall

This study shows that specific O-glycosylation of Ebola virus glycoprotein affects viral infectivity and identifies key host enzymes involved in this process.

bioRxiv · Apr 25, 2022 · PreprintMicrobiology

In-vitro virucidal activity of hypothiocyanite and hypothiocyanite/lactoferrin mix against SARS-CoV-2

L. Cegolon, M. Mirandola, C. Salaris, M. V. Salvati, C. Salata, G. Mastrangelo

This study evaluates the virucidal activity of hypothiocyanite and its combination with lactoferrin against SARS-CoV-2 in vitro, showing dose-dependent antiviral effects without cytotoxicity.

bioRxiv · Nov 17, 2020Microbiology